CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-01 | Loerop James Chief Business Officer | Shares withheld for taxes | −10,686 | $3.51 | $38K | 177,322 |
| 2026-02-01 | Loerop James Chief Business Officer | Option exercise · Restricted Stock Units | −11,250 | 0 | ||
| 2026-02-01 | Loerop James Chief Business Officer | Option exercise · Resticted Stock Units | −7,500 | 7,500 | ||
| 2026-02-01 | Loerop James Chief Business Officer | Option exercise · Restricted Stock Units | −14,750 | 29,500 | ||
| 2026-02-01 | Balthaser Kevin Chief Financial Officer | Option exercise | +14,750 | 175,163 | ||
| 2026-02-01 | Balthaser Kevin Chief Financial Officer | Shares withheld for taxes | −4,984 | $3.51 | $17K | 170,179 |
| 2026-02-01 | Balthaser Kevin Chief Financial Officer | Option exercise · Restricted Stock Units | −14,750 | 29,500 | ||
| 2026-01-02 | Balthaser Kevin Chief Financial Officer | Option exercise | +13,200 | 164,874 | ||
| 2026-01-02 | Balthaser Kevin Chief Financial Officer | Shares withheld for taxes | −4,461 | $2.88 | $13K | 160,413 |
| 2026-01-02 | Balthaser Kevin Chief Financial Officer | Option exercise · Restricted Stock Units | −13,200 | 13,600 | ||
| 2026-01-02 | Loerop James Chief Business Officer | Option exercise | +18,150 | 161,212 | ||
| 2026-01-02 | Loerop James Chief Business Officer | Shares withheld for taxes | −6,171 | $2.88 | $18K | 155,041 |
| 2026-01-02 | Loerop James Chief Business Officer | Option exercise · Restricted Stock Units | −18,150 | 18,700 | ||
| 2026-01-02 | Walker Neal CEO | Option exercise | +29,150 | 1,508,974 | ||
| 2026-01-02 | Walker Neal CEO | Shares withheld for taxes | −9,952 | $2.88 | $29K | 1,499,022 |
| 2026-01-02 | Walker Neal CEO | Option exercise · Restricted Stock Units | −29,150 | 30,034 | ||
| 2026-01-01 | Balthaser Kevin Chief Financial Officer | Option exercise | +7,500 | 153,924 | ||
| 2026-01-01 | Balthaser Kevin Chief Financial Officer | Shares withheld for taxes | −2,250 | $3.01 | $7K | 151,674 |
| 2026-01-01 | Balthaser Kevin Chief Financial Officer | Option exercise · Restricted Stock Units | −7,500 | 7,500 | ||
| 2025-12-31 | Balthaser Kevin Chief Financial Officer | Option exercise | +73,750 | 166,358 |
Page 4 of 34 · 680 trades